Euroasian Journal of Hepato-Gastroenterology

Register      Login

VOLUME 10 , ISSUE 1 ( January-June, 2020 ) > List of Articles

CASE REPORT

Benign Hepatic Nodules Mimicking Hepatocellular Carcinoma in the Setting of Fontan-associated Liver Disease: A Case Report

Anıl Çolaklar, Stephen J Lehnert, Temel Tirkes

Keywords : Congenital heart disease, Fontan procedure, Imaging features, Liver lesion

Citation Information : Çolaklar A, Lehnert SJ, Tirkes T. Benign Hepatic Nodules Mimicking Hepatocellular Carcinoma in the Setting of Fontan-associated Liver Disease: A Case Report. Euroasian J Hepatogastroenterol 2020; 10 (1):42-44.

DOI: 10.5005/jp-journals-10018-1315

License: CC BY-NC 4.0

Published Online: 01-06-2020

Copyright Statement:  Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Fontan procedure, in which systemic circulation is redirected into pulmonary circulation by a baffle, is a palliative surgical strategy for patients born with single ventricle congenital heart disease. Hemodynamic changes secondary to Fontan procedure, also termed as Fontan physiology, result in end-organ damage, especially of the liver. Fontan-associated liver disease (FALD) represents a spectrum of pathologies ranging from mild liver fibrosis to advanced liver cirrhosis and hepatocellular carcinoma (HCC). Hepatic nodules, some of which have been documented as HCC in several case series and reports, are a recognized complicated feature of FALD. Herein, we report a case with benign hepatic nodules mimicking HCC by imaging characteristics, emphasizing the fact that arterially enhancing lesions with delayed washout appearance may reflect benign regenerative or focal nodular hyperplasia-like nodules in patients with Fontan physiology.


PDF Share
  1. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971;26(3):240–248. DOI: 10.1136/thx.26.3.240.
  2. Davies RR, Chen JM, Mosca RS. The Fontan procedure: evolution in technique; attendant imperfections and transplantation for “failure”. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2011;14(1):55–66. DOI: 10.1053/j.pcsu.2011.01.014.
  3. Gordon-Walker TT, Bove K, Veldtman G. Fontan-associated liver disease: A review. J Cardiol 2019;74(3):223–232. DOI: 10.1016/j.jjcc.2019.02.016.
  4. Tellez L, Rodriguez de Santiago E, Albillos A. Fontan-associated liver disease. . Rev Esp Cardiol (Engl Ed) 2018;71(3):192–202. DOI: 10.1016/j.recesp.2017.10.014.
  5. Wells ML, Hough DM, Fidler JL, et al. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma. Abdom Radiol (NY) 2017;42(11):2623–2631. DOI: 10.1007/s00261-017-1181-9.
  6. Asrani SK, Asrani NS, Freese DK, et al. Congenital heart disease and the liver. Hepatology 2012;56(3):1160–1169. DOI: 10.1002/hep.25692.
  7. Kendall TJ, Stedman B, Hacking N, et al. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol 2008;61(4):504–508. DOI: 10.1136/jcp.2007.052365.
  8. Pundi K, Pundi KN, Kamath PS, et al. Liver disease in patients after the Fontan operation. Am J Cardiol 2016;117(3):456–460. DOI: 10.1016/j.amjcard.2015.11.014.
  9. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005;129(6):1348–1352. DOI: 10.1016/j.jtcvs.2004.10.005.
  10. Asrani SK, Warnes CA, Kamath PS. Hepatocellular carcinoma after the Fontan procedure. N Engl J Med 2013;368(18):1756–1757. DOI: 10.1056/NEJMc1214222.
  11. Elder RW, Parekh S, Book WM. More on hepatocellular carcinoma after the Fontan procedure. N Engl J Med 2013;369(5):490. DOI: 10.1056/NEJMc1306854.
  12. Kwon S, Scovel L, Yeh M, et al. Surgical management of hepatocellular carcinoma after Fontan procedure. J Gastrointest Oncol 2015;6(3):E55–E60.
  13. Yamada K, Shinmoto H, Kawamura Y, et al. Transarterial embolization for pediatric hepatocellular carcinoma with cardiac cirrhosis. Pediatr Int 2015;57(4):766–770. DOI: 10.1111/ped.12619.
  14. Takuma Y, Fukada Y, Iwadou S, et al. Surgical resection for hepatocellular carcinoma with cardiac cirrhosis after the Fontan procedure. Intern Med. 2016;55(22):3265–3272. DOI: 10.2169/internalmedicine.55.6869.
  15. Oh C, Youn JK, Han JW, et al. Hepatocellular carcinoma after the Fontan procedure in a 16-year-old girl: A case report. Medicine (Baltimore) 2016;95(41):e4823. DOI: 10.1097/MD.0000000000004823.
  16. Josephus Jitta D, Wagenaar LJ, Mulder BJ, et al. Three cases of hepatocellular carcinoma in Fontan patients: Review of the literature and suggestions for hepatic screening. Int J Cardiol 2016;206:21–26. DOI: 10.1016/j.ijcard.2015.12.033.
  17. Conroy MR, Moe TG. Hepatocellular carcinoma in the adult Fontan patient. Cardiol Young. 2017;27(2):407–409. DOI: 10.1017/S1047951116001360.
  18. Martinez-Quintana E, Monescillo A, Rodriguez-Gonzalez F. Hepatocellular carcinoma in a non-failing Fontan circulation. Rev Esp Enferm Dig 2017;109(5):375.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.